Friday, November 5, 2010

Mesothelioma Survival Rate

Mesothelioma Survival Rate: An Introduction

Mesothelioma survival rate indicates the percentage of people with a particular type and stage of mesothelioma who survive the disease for a certain period after their diagnosis. In most cases, statistics refer to the survival rate at 5 years mesothelioma. The 5-year survival mesothelioma is the percentage of people who are alive 5 years after a diagnosis of mesothelioma, if they have little or no signs or symptoms of mesothelioma, are free of the disease or are under treatment for mesothelioma.

Survival rate of mesothelioma is based on large groups of people, and can not be used to predict what will happen in particular for the patient. No two patients are exactly alike, and the treatment of mesothelioma and response to therapy vary widely.

Factors Influencing the Mesothelioma Survival Rate

In general, the mesothelioma survival rate will depend on:

*The stage of mesothelioma (see Mesothelioma Stages)

*The size of the tumor

*Whether the tumor can be removed by surgical procedure

*The amount of fluid in the chest or abdomen

*The patient's age plus general health, including lung plus heart health

*The type of mesothelioma cancer cells plus how they look under a microscope

*Whether the mesothelioma has been diagnosed or has come back.

Overall Mesothelioma Survival Rate

Survival rates can be calculated by different methods for different purposes. The survival rates presented here are the relative survival rate. The relative survival rate measures for the conservation of mesothelioma patients, compared to the population to assess the impact of cancer. Overall 5-year relative survival rate of mesothelioma from 1998 to 2002 was about 9 per cent.

Below are the relative survival rates for each year following a mesothelioma diagnosis:

*Year 1 mesothelioma survival rate: 39 percent

*Year 2 survival rate: 20 percent

*Year 3 survival rate: 11 percent

*Year 4 survival rate: 10 percent

*Year 5 survival rate: 9 percent.

No comments:

Post a Comment